| Literature DB >> 27834805 |
Renato José Silva-Oliveira1, Gabriela Francine Lopes2, Luiz Fernando Camargos3, Ana Maciel Ribeiro4, Fábio Vieira Dos Santos5, Richele Priscila Severino6, Vanessa Gisele Pasqualotto Severino7, Ana Paula Terezan8, Ralph Gruppi Thomé9, Hélio Batista Dos Santos10, Rui Manuel Reis11,12,13, Rosy Iara Maciel de Azambuja Ribeiro14.
Abstract
Cancer of the head and neck is a group of upper aerodigestive tract neoplasms in which aggressive treatments may cause harmful side effects to the patient. In the last decade, investigations on natural compounds have been particularly successful in the field of anticancer drug research. Our aim is to evaluate the antitumor effect of Tapirira guianensis Aubl. extracts on a panel of head and neck squamous cell carcinoma (HNSCC) cell lines. Analysis of secondary metabolites classes in fractions of T. guianensis was performed using Nuclear Magnetic Resonance (NMR). Mutagenicity effect was evaluated by Ames mutagenicity assay. The cytotoxic effect, and migration and invasion inhibition were measured. Additionally, the expression level of apoptosis-related molecules (PARP, Caspases 3, and Fas) and MMP-2 was detected using Western blot. Heterogeneous cytotoxicity response was observed for all fractions, which showed migration inhibition, reduced matrix degradation, and decreased cell invasion ability. Expression levels of MMP-2 decreased in all fractions, and particularly in the hexane fraction. Furthermore, overexpression of FAS and caspase-3, and increase of cleaved PARP indicates possible apoptosis extrinsic pathway activation. Antiproliferative activity of T. guianensis extract in HNSCC cells lines suggests the possibility of developing an anticancer agent or an additive with synergic activities associated with conventional anticancer therapy.Entities:
Keywords: HNSCC; alkaloids; apoptosis markers; cytotoxic activity
Mesh:
Substances:
Year: 2016 PMID: 27834805 PMCID: PMC5133839 DOI: 10.3390/ijms17111839
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Revertant/plate, standard deviation and mutagenicity index (MI) in the strains TA98 and TA100 of S. typhimurium after treatment with different doses of the extract from T. guianensis, without (−S9) and with (+S9) metabolic activation.
| Treatment | TA98 | TA100 | ||||||
|---|---|---|---|---|---|---|---|---|
| −S9 | +S9 | −S9 | +S9 | |||||
| Mean ± SD | MI | Mean ± SD | MI | Mean ± SD | MI | Mean ± SD | MI | |
| NC | 16.7 ± 6.0 | – | 41.7 ± 5.69 | – | 121.7 ± 18.2 | – | 97.00 ± 40.85 | – |
| Extract (µg/mL) | – | – | – | – | – | – | – | – |
| 4.25 | 56.0 ± 11.0 * | 3.3 | 140.3 ± 87.5 ** | 3.4 | 130.0 ± 37.2 | 1.1 | 198.7 ± 24.5 * | 2.0 |
| 8.67 | 67.3 ± 16.3 * | 4.0 | 180.7 ± 42.2 * | 4.3 | 118.0 ± 74.6 | 1.0 | 232.0 ± 8.9 * | 2.4 |
| 16.68 | 136.0 ± 16.7 * | 8.1 | 309.7 ± 74.6 * | 7.4 | 68.7 ± 33.1 | 0.6 | 250.7 ± 35.2 * | 2.6 |
| 24.09 | 186.0 ± 29.9 * | 11.1 | 423.7 ± 60.5 * | 10.2 | 110.7 ± 11.5 | 0.9 | 306.3 ± 31.2 * | 3.2 |
| 30.97 | 246.3 ± 43.7 * | 14.7 | 315.0 ± 10.5 * | 7.6 | 119.7 ± 29.0 | 1.0 | 308.3 ± 41.4 * | 3.2 |
| PC | 426.3 ± 40.3 * | – | 2839.7 ± 515.3 * | – | 471.0 ± 194.2 * | – | 1257.3 ± 159.3 * | – |
Mean ± SD: Revertants Mean Frequency per plate ± Standard Deviation; MI: Mutagenicity Index; NC: Negative Control (DMSO − 80 µL/plate); PC: Positive Control 4-nitro-o-phenylenediamine (10 μg/plate − TA98 (−S9)), Methylmethane sulfonate (260 μg/plate − TA100 (−S9)) or 2-Aminoanthracene (5 μg/plate − TA98 (+S9) and TA100 (+S9)); * p < 0.05 and MI > 2; ** MI > 2.
Classification and IC50 value response to different fractions of the T. guianensis extract in HNSCC cell lines.
| Cell Line | Anatomic Site | IC50 Value (Mean ± DP) mg/mL | |||
|---|---|---|---|---|---|
| – | – | C1 | C2 | C3 | C4 |
| SCC14 | Hypopharynx | 0.029 ± 0.0007 | 0.014 ± 0.002 | 0.058 ± 0.002 | 0.074 ± 0.002 |
| SCC25 | Oral Cavity | 0.244 ± 0.048 | 0.240 ± 0.026 | 0.349 ± 0.056 | 0.592 ± 0.020 |
| Fadu | Hypopharynx | 0.050 ± 0.002 | 0.023 ± 0.002 | 0.056 ± 0.003 | 0.186 ± 0.018 |
| HN13 | Tongue | 0.028 ± 0.0002 | 0.015 ± 0.002 | 0.045 ± 0.004 | 0.058 ± 0.001 |
Growth inhibition to different fractions of the T. guianensis extract in HSCC cell lines.
| Cell Line | GI Classification at 0.05 mg/mL (%) | |||
|---|---|---|---|---|
| – | C1 | C2 | C3 | C4 |
| SCC14 | MS (58.3%) | HS (63.3%) | MS (55.3%) | MS (46.7%) |
| SCC25 | R (25.3%) | R (28%) | R (25%) | R (0%) |
| Fadu | MS (47%) | HS (66.3%) | MS (50.3%) | MS (47.3%) |
| HN13 | MS (58.3%) | HS (66.3%) | MS (55.3%) | MS (46.6%) |
HS: highly sensitive; MS: moderate sensitive and R: resistant.
Figure 1Cytotoxicity profile of SCC14, SCC25, Fadu, HN13 head and neck tumor cell lines, exposed to the different fractions of the T. guianensis extract: (A) Ethyl acetate (C1); (B) Hydroalcoholic (C2); (C) Crude extract (C3); and (D) Hexane (C4). Bars represent the cell viability at 50 µg/mL. Bars represent the GI score classification. Green (HS: highly sensitive); Orange (MS: moderate sensitive) and Red (R: resistant).
Figure 2(A) Representative images of wound healing assay of HN13 cell line after 24 h, exposed to ethyl acetate fraction (25 μg/mL), hydroalcoholic fraction (10 μg/mL), crude extract (50 μg/mL) and hexane fraction (60 μg/mL). The red lines represent the distance between both edges of the wound; Scale bars, 200 μm; (B) bars represent the relative migration expressed as the means ± SD for different compounds. All experiments were repeated for three times. * p < 0.05; ** p < 0.01.
Figure 3Effect of crude extract (C3) and fractions (C1, C2 and C4) of T. guianensis on HN13 cellular migration and invasion. (A) Invasion was measured at 24 h by Matrigel invasion assay, the results were expressed in relation to the DMSO control (considered as 100% of invasion) as the mean percentage of invasion ± SD; (B) analysis of index cell migration measured at 24 h by trans-well, the results are expressed as the means ± SD; (C) western blot analysis using the antibodies of anti-human MMP-2. The cells lines were incubated with compounds for 24 h; (D,E) representative images (at ×40 magnification) of migration and invasion assays, respectively. * p < 0.05; ** p < 0.01.
Figure 4Effect of crude extract (C3) and fractions (C1, C2 and C4) of T. guianensis on intracellular signaling pathway activation in HN13 cells. HN13 cell lines were incubated with compounds (IC50 values) for 24 h. (A) Western blot, using the antibodies of anti-human PARP (Full Length: 116 kDa and cleaved: 89 kDa), Caspase 3 (Full Length: 35 kDa), Caspase 9 (cleaved: 19 kDa) Fas (40 kDa) and TNFR1 (55 kDa) and Actin (45 kDa); (B–F) densitometric analysis of Western blot data of the four proteins. Bars results are expressed as the means ± SD. * p < 0.05; ** p < 0.01.